These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 21295469

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Entry into a new class of protein kinase inhibitors by pseudo ring design.
    Furet P, Caravatti G, Guagnano V, Lang M, Meyer T, Schoepfer J.
    Bioorg Med Chem Lett; 2008 Feb 01; 18(3):897-900. PubMed ID: 18248988
    [Abstract] [Full Text] [Related]

  • 4. Novel 8-arylated purines as inhibitors of glycogen synthase kinase.
    Ibrahim N, Mouawad L, Legraverend M.
    Eur J Med Chem; 2010 Aug 01; 45(8):3389-93. PubMed ID: 20472330
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Discovery and structure-activity relationship of 3-aminopyrid-2-ones as potent and selective interleukin-2 inducible T-cell kinase (Itk) inhibitors.
    Charrier JD, Miller A, Kay DP, Brenchley G, Twin HC, Collier PN, Ramaya S, Keily SB, Durrant SJ, Knegtel RM, Tanner AJ, Brown K, Curnock AP, Jimenez JM.
    J Med Chem; 2011 Apr 14; 54(7):2341-50. PubMed ID: 21391610
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Discovery of novel thieno[2,3-d]pyrimidin-4-yl hydrazone-based inhibitors of cyclin D1-CDK4: synthesis, biological evaluation and structure-activity relationships. Part 2.
    Horiuchi T, Nagata M, Kitagawa M, Akahane K, Uoto K.
    Bioorg Med Chem; 2009 Dec 01; 17(23):7850-60. PubMed ID: 19889545
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Discovery of aryl aminoquinazoline pyridones as potent, selective, and orally efficacious inhibitors of receptor tyrosine kinase c-Kit.
    Hu E, Tasker A, White RD, Kunz RK, Human J, Chen N, Bürli R, Hungate R, Novak P, Itano A, Zhang X, Yu V, Nguyen Y, Tudor Y, Plant M, Flynn S, Xu Y, Meagher KL, Whittington DA, Ng GY.
    J Med Chem; 2008 Jun 12; 51(11):3065-8. PubMed ID: 18447379
    [Abstract] [Full Text] [Related]

  • 14. Discovery of novel thieno[2,3-d]pyrimidin-4-yl hydrazone-based inhibitors of Cyclin D1-CDK4: synthesis, biological evaluation, and structure-activity relationships.
    Horiuchi T, Chiba J, Uoto K, Soga T.
    Bioorg Med Chem Lett; 2009 Jan 15; 19(2):305-8. PubMed ID: 19091560
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Discovery of imidazo[1,2-a]pyrazine-based Aurora kinase inhibitors.
    Belanger DB, Curran PJ, Hruza A, Voigt J, Meng Z, Mandal AK, Siddiqui MA, Basso AD, Gray K.
    Bioorg Med Chem Lett; 2010 Sep 01; 20(17):5170-4. PubMed ID: 20674350
    [Abstract] [Full Text] [Related]

  • 17. Design, synthesis, and thrombin-inhibitory activity of pyridin-2-ones as P2/P3 core motifs.
    Hanessian S, Simard D, Bayrakdarian M, Therrien E, Nilsson I, Fjellström O.
    Bioorg Med Chem Lett; 2008 Mar 15; 18(6):1972-6. PubMed ID: 18289852
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Design, synthesis and evaluation of highly selective pyridone-based class II MET inhibitors.
    She N, Zhuo L, Jiang W, Zhu X, Wang J, Ming Z, Zhao X, Cong X, Huang W.
    Bioorg Med Chem Lett; 2014 Aug 01; 24(15):3351-5. PubMed ID: 24951334
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.